Imatinib Mesylate 50 mg, 100 mg, 400 mg Suppliers & Bulk Manufacturers
Available Forms: Tablet / Capsule
Available Strengths: 50 mg, 100 mg, 400 mg
Reference Brands: Gleevec (EU & US), Veenat (India)
Category: Oncology Cancer Care
Imatinib Mesylate is available in oral tablet form, with common strengths of 100 mg, 400 mg, and 50 mg. The drug is sold under the brand Gleevec® (by Novartis) and also in generic versions from manufacturers like Teva, Sandoz, and Mylan. It is widely used in the US and EU for treating cancers such as chronic myeloid leukemia (CML) and gastrointestinal stromal tumors (GISTs).
Product Description:
Imatinib Mesylate is a targeted therapy used in oncology to treat chronic myeloid leukemia (CML), gastrointestinal stromal tumors (GISTs), and other cancers. Available under the brand Gleevec® by Novartis and as generics, Imatinib is an essential tyrosine kinase inhibitor (TKI) used in cancer centers, hospitals, and oncology clinics. It blocks the action of abnormal proteins that contribute to cancer cell growth, making it crucial for effective cancer management. Available in oral tablets and generics, Imatinib Mesylate is widely sourced by B2B pharmaceutical wholesalers in the US and EU, ensuring reliable supply and GMP-compliant distribution for cancer treatment.
Imatinib Mesylate — third party manufacturing & bulk supply
Imatinib Mesylate 50 mg, 100 mg, 400 mg is available through PharmaTradz for wholesale and bulk supply as well as on a third party (contract) manufacturing basis. Buyers sourcing this product generally take one of three routes:
What to include when you enquire
- Destination market — determines which manufacturers hold the right site-level approvals
- First order quantity and estimated annual volume
- Whether you need a registration dossier or the product is already registered
- Packaging, labelling and language requirements
- Incoterms and required shelf life
Manufacturers of Imatinib Mesylate listed on PharmaTradz hold site-level approvals across WHO-GMP, EU-GMP, USFDA, ANVISA and TGA, verified at onboarding. Narcotic drugs and controlled substances are supplied strictly against valid import and export permits issued by the competent authorities.
Request a quote for Imatinib Mesylate →The Trade Mark owner has been correctly identified under the heading Manufacturer / TM Owner as required by the Act.
Frequently Asked Questions
Imatinib Mesylate is used to treat certain types of cancer, particularly chronic myeloid leukemia (CML) and Philadelphia chromosome-positive acute lymphoblastic leukemia (Ph+ ALL). It is also used for gastrointestinal stromal tumors (GIST) and some other rare cancers.
Imatinib Mesylate is a synthetic small-molecule tyrosine kinase inhibitor. It works by blocking specific enzymes known as tyrosine kinases that promote the growth and multiplication of cancer cells.
The most widely known trade names are Gleevec and Glivec.
The original brand was developed and manufactured by Novartis, while many other pharmaceutical companies manufacture generic versions worldwide.
The generic name is Imatinib Mesylate.
Brand names include Gleevec, Glivec, Veenat, and Imatib.
Imatinib Mesylate is manufactured in several countries including the United States, Switzerland, India, and other global pharmaceutical manufacturing hubs depending on the manufacturer.
Related Products
Fruquin 5 Mg (Fruquintinib)
Strength:
5 Mg
Form: Capsules
Reference Brands: Everest Bangladesh altd.
View Details
Vorinostat
Strength:
100 mg
Form: Capsules
Reference Brands: Zolinza (USA/EU), Vornat (India)
View Details
Panobinostat Lactate
Strength:
10 mg, 15 mg, 20 mg
Form: Capsules
Reference Brands: Farydak (USA/EU),
View Details
Gilteritinib
Strength:
40 mg
Form: Tablets
Reference Brands: Xospata (USA/India), LuciGil (Asia)
View DetailsQuick Response Guaranteed | Verified Suppliers
